Nobody will remember: • Your salary • How busy you were • How many hours you worked People will remember: • When I stopped falling asleep in meetings • How small my AirMini is • My first myAir score of 100
ResMed
Herstellung medizinischer Geräte
San Diego, CA 187,971 followers
Pioneering innovative medical device and digital health solutions that treat and keep people out of the hospital.
Über uns
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
- Website
-
https://www.resmed.com
External link for ResMed
- Industrie
- Herstellung medizinischer Geräte
- Größe des Unternehmens
- 5,001-10,000 employees
- Hauptsitz
- San Diego, CA
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1989
- Spezialitäten
- Sleep apnea, COPD, Out-of-hospital care, Home medical equipment, durable medical equipment, SaaS, CPAP, remote monitoring, patient engagement, Sleep, Respiratory care, medical devices, health IT, digital health, medical software, portable oxygen, ventilation, interoperability, and medical technology
Standorte
Employees at ResMed
Aktualisierungen
-
Zen Room Vibes in Shanghai Imagine a tranquil evening blending soothing breathing exercises, electronic beats, and serene meditation—sounds like a dream, right? 🌙 The ResMed café hosted its first wellness retreat, perfect for unwinding after a busy day. Each guest enjoyed a refreshing caffeine-free signature drink and received a gift card for a home sleep screening ring—ideal for improving sleep health and sharing with loved ones. We plan to continue these sessions, providing the community with a consistent opportunity to unwind, connect, and rejuvenate.
-
-
Announcing the second in our series of scientific sessions at #ERSCongress, all focused on putting patients at the centre of care: 📆 Join us in Vienna on Sunday 8 September from 15:30 to 16:15 CET for ‘Complementary ways of generating evidence with #OSA therapies’. Attend this session, chaired by Esther Irene Schwarz and Raphael Heinzer, to learn about new and traditional methods of gathering relevant clinical insights from our expert speakers: 💡 Manuel Sánchez-de-la-Torre: What have we learned from post-hoc and on-treatment analysis of RCTs with #CPAP on cardiovascular outcomes? 💡 Professor Jean-Louis Pépin: Exploring alternative study designs in OSA Interested? Follow this link to add it to your calendar and find our full #ERS2024 programme👉 https://lnkd.in/ewF7iCvd European Respiratory Society
-
-
As a long-distance lorry driver, Michel's life and livelihood were being blighted by the symptoms of #SleepApnea. That is until ResMed’s digital health technology and #CPAP therapy helped steer him back to better sleep and safer driving – and reconnected him with his passion for running along the way 🏃♂️ In this touching film produced for us by BBC StoryWorks as part of their #ConnectingTheDots series, discover how Michel got his breath – and his life – back 😌💪🎬👉 https://lnkd.in/dmVJU3vP
-
ResMed reposted this
This week for Pulmonary Chat: Understanding Obstructive Sleep Apnea: The Basics Join us next Tuesday, August 20th at 4:30 Eastern / 1:30 Pacific Time for an informative webinar that delves into the fundamentals of obstructive sleep apnea (OSA). In this session, you'll learn what OSA is, how it affects your health, and the common signs and symptoms to watch for. We'll explore diagnostic methods, treatment options, and lifestyle changes that can help manage this condition effectively. Whether you're newly diagnosed, suspect you might have OSA, or just want to understand more about this sleep disorder, this webinar provides essential insights to improve your sleep and overall well-being. Our featured speaker is Luciana Rabello, Director of Clinical Advocacy at ResMed Luciana is a Physical Therapist with a solid background in Respiratory Therapy, Sleep Medicine and Clinical Education. Doctoral degree in Science, with published manuscripts and book chapters in the area of respiratory care and non-invasive ventilation. Currently leads the Clinical Advocacy team for ResMed in North America and China. To register for this event: go to https://lnkd.in/eXx8bsKd
-
-
There’s less than a month until #ERS2024 and we’re looking forward to putting our programme into action! 👉 https://lnkd.in/gw5r-x9q 📆 We’ll be at the event in Vienna from 8 to 10 September, with a trio of scientific sessions focused on putting #patients at the centre of care – presented by some of the most respected names in #RespiratoryMedicine. Follow our feed for details... There’ll also be the chance to meet our team at our booth and see some of our solutions designed to improve your patients’ lives – and make yours easier. European Respiratory Society
-
-
“When I got the CPAP machine, it just completely changed my life. Day-to-day, I just feel sharper. It changed everything: concentration, how I perform at work, how I perform hanging out with friends and not falling asleep. For that, I’m super grateful.” Diagnosed at a young age, Julia’s story is a powerful reminder that sleep apnea knows no age and can impact anyone, even those in their 20s. Seeking treatment has changed her life for the better, allowing her to excel in all aspects of life. No matter your walk of life or your age, share your PAP therapy journey and inspire others with #PAPSavedMyLife. This testimonial is a genuine and documented account of the individual’s response to treatment. Outcomes and results may vary, and this individual’s response does not provide any indication, warranty or guarantee that other people will have the same or a similar experience. Talk to your healthcare professional for further information.
-
-
"The kinetics of flow of patients for every year between now and 2050 are going to improve with this class of medications because they bring in people into primary care, they get prescriptions, and they get diagnosed with other diseases including sleep apnea and insomnia." Our CEO, Michael "Mick" Farrell, and Chief Medical Officer, Carlos Nunez, joined Adam Spielman from Citi Global Insights to discuss #GLP1s' impact on the future of #SleepApnea. https://lnkd.in/ean-35Kj
-
Our CEO, Michael "Mick" Farrell, recently joined Oliver Renick from the Schwab Network to discuss our latest earnings and the advancements in wearables, #AI, and #GLP1s, and their impact on #CPAP therapy. https://lnkd.in/egyWAa4B
ResMed (RMD) CEO on GLP-1 Drugs: "This is a Really Exciting Moment for Global Healthcare System" | Schwab Network
schwabnetwork.com
-
A recent study highlights the crucial role of sleep for elite athletes' recovery, performance readiness, and immune response. By establishing sleep-quality reference ranges using the Pittsburgh Sleep Quality Index (PSQI), the research found that 39.43% of 1,603 Team USA athletes reported poor sleep. Notable differences include men having better overall PSQI scores and later bedtimes compared to women, Winter Games athletes sleeping later than Summer Games participants, and individual-sport athletes having a lower risk of reduced sleep duration than team-sport athletes. These findings offer valuable insights for designing targeted #sleep interventions, helping to identify athletes at greatest risk for poor sleep. This paves the way for tailored sleep strategies, ensuring our athletes achieve peak performance. Let's prioritize sleep to support our athletes in reaching their best! 🥇 https://lnkd.in/eQixgfzR Source: Anderson T, Galan-Lopez N, Taylor L, Post EG, Finnoff JT, Adams WM. Sleep Quality in Team USA Olympic and Paralympic Athletes. Int J Sports Physiol Perform. 2024 Jan 22;19(4):383-392. doi: 10.1123/ijspp.2023-0317. PMID: 38253047.
-
Verbundene Seiten
Ähnliche Seiten
Jobs durchsuchen
Aktie
RMD
NYSE
20 Minuten Verzögerung
$242.69
0.44 (0.182%)
- Öffnen Sie
- 240.54
- Niedrig
- 239.37
- Hoch
- 246.8
Daten von Refinitiv
Siehe mehr Informationen auf